Bihui Xu

5.0k total citations · 2 hit papers
5 papers, 1.9k citations indexed

About

Bihui Xu is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Bihui Xu has authored 5 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Bihui Xu's work include Cancer Immunotherapy and Biomarkers (2 papers), Immune Cell Function and Interaction (2 papers) and Immunotherapy and Immune Responses (2 papers). Bihui Xu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Immune Cell Function and Interaction (2 papers) and Immunotherapy and Immune Responses (2 papers). Bihui Xu collaborates with scholars based in United States and Netherlands. Bihui Xu's co-authors include Andy J. Minn, Hemant Ishwaran, Yu Qiu, Tony J. Wu, Christina Twyman-Saint Victor, Joseph L. Benci, E. John Wherry, Mirjam C. Boelens, Jos Jonkers and Joyce M. Slingerland and has published in prestigious journals such as Cell, Genome biology and Nature Cancer.

In The Last Decade

Bihui Xu

5 papers receiving 1.8k citations

Hit Papers

Tumor Interferon Signaling Regulates a Multigenic Resista... 2014 2026 2018 2022 2016 2014 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bihui Xu United States 5 950 924 872 537 209 5 1.9k
Tony J. Wu United States 3 779 0.8× 779 0.8× 1.0k 1.2× 641 1.2× 169 0.8× 3 1.8k
Christina Twyman-Saint Victor United States 4 826 0.9× 747 0.8× 735 0.8× 474 0.9× 158 0.8× 4 1.6k
Kathryn E. Yost United States 15 1.1k 1.2× 1.1k 1.2× 1.1k 1.2× 444 0.8× 113 0.5× 21 2.3k
Natalie B. Collins United States 10 963 1.0× 826 0.9× 775 0.9× 189 0.4× 162 0.8× 21 1.7k
Anne M. van der Leun Netherlands 8 1.0k 1.1× 1000 1.1× 567 0.7× 228 0.4× 240 1.1× 9 1.6k
Elisabeth J. M. Huijbers Netherlands 19 486 0.5× 432 0.5× 697 0.8× 347 0.6× 146 0.7× 35 1.3k
Amandine Alard United States 10 851 0.9× 724 0.8× 576 0.7× 169 0.3× 315 1.5× 13 1.6k
Jesse M. Zaretsky United States 8 1.5k 1.6× 1.3k 1.4× 518 0.6× 183 0.3× 278 1.3× 16 2.1k
Munehide Nakatsugawa Japan 21 783 0.8× 683 0.7× 672 0.8× 193 0.4× 128 0.6× 79 1.4k
Karsten A. Pilones United States 16 1.4k 1.5× 1.1k 1.2× 449 0.5× 236 0.4× 342 1.6× 41 2.0k

Countries citing papers authored by Bihui Xu

Since Specialization
Citations

This map shows the geographic impact of Bihui Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bihui Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bihui Xu more than expected).

Fields of papers citing papers by Bihui Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bihui Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bihui Xu. The network helps show where Bihui Xu may publish in the future.

Co-authorship network of co-authors of Bihui Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Bihui Xu. A scholar is included among the top collaborators of Bihui Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bihui Xu. Bihui Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Qiu, Jingya, Bihui Xu, Darwin Ye, et al.. (2023). Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction. Nature Cancer. 4(1). 43–61. 61 indexed citations
2.
Zhou, Zilu, Bihui Xu, Andy J. Minn, & Nancy R. Zhang. (2020). DENDRO: genetic heterogeneity profiling and subclone detection by single-cell RNA sequencing. Genome biology. 21(1). 10–10. 35 indexed citations
3.
Benci, Joseph L., Lexus R. Johnson, Ruth Choa, et al.. (2019). Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade. Cell. 178(4). 933–948.e14. 304 indexed citations
4.
Benci, Joseph L., Bihui Xu, Yu Qiu, et al.. (2016). Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade. Cell. 167(6). 1540–1554.e12. 804 indexed citations breakdown →
5.
Boelens, Mirjam C., Tony J. Wu, Barzin Y. Nabet, et al.. (2014). Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways. Cell. 159(3). 499–513. 660 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026